The9 Limited (NCTY) has signed a definitive share purchase agreement with WM Therapeutic Co., Ltd. to purchase an additional 21.7% shares of WM Therapeutic by cash and issuance of The9's restricted shares. The9 will pay cash consideration of $1.5 million and will issue 251,290,500 restricted Class A ordinary shares to WM Therapeutic.
The9 had invested 8.3% shares of WM Therapeutic in 2021. With the new agreement, The9 will own 30% of WM Therapeutic. The9 is granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.
Shares of The9 Limited are up 8% in pre-market trade on Tuesday.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.